The number of confirmed Ebola cases in the Democratic Republic of Congo has climbed to 260 as officials updated their estimates of the outbreak’s size and international health organizations warned of the risk of further spread.
Health Minister Roger Kamba reported the revised tally Saturday at a press conference in Bunia, the city at the epicenter of the outbreak, and said US health authorities had agreed to support Congo’s use of an experimental antibody treatment in a mid-stage trial. The research will help determine the efficacy of the medication, “which is very promising,” he said.
Read more:
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.